Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Clinicians dive into the impact of sickle cell on quality of life and symptom...

Secukinumab is the only fully human biologic that directly inhibits...

  • This Just In! The #FDA has approved secukinumab (Cosentyx) as a treatment for moderate to severe plaque psoriasis in pediatric patients at least 6 years old who are candidates for systemic therapy or phototherapy. https://t.co/vKkhXpZ6Qj - view on twitter

All patients with severe disease had abnormal ECG...

  • “These findings may suggest that severe #SCA is associated with #cardiovascular abnormalities like left atrial abnormality, intraventricular conduction abnormalities, increased risk of arrhythmias, and sudden death." https://t.co/Coj5Xd3Q0L - view on twitter

Misha Rosenbach, MD, discusses how rising temperatures and climate change, issues of public health concern, are relevant to the field of...

The oral combination therapy can also be used as acute treatment for manic or mixed...

Esophageal cancer has a low survival rate largely due to advanced stage...

The treatment is also being studied for safety and efficacy in patients with Crohn’s...

  • ICYMI: The #FDA last week approved ozanimod (Zeposia) 0.92 mg, an oral agent that selectively targets sphingosine-1-phosphate receptor subtypes 1 and 5, for adult patients with moderately to severely active ulcerative colitis. https://t.co/dtMiVVkiWM - view on twitter

Misha Rosenbach, MD, discusses how rising temperatures and climate change, issues of public health concern, are relevant to the field of...

The oral combination therapy can also be used as acute treatment for manic or mixed...